Radiosensitivity of human biliary tract cancer cell lines in vitro

International Journal of Oncology

Volumn 10, Issue 3, 1997, Pages 545-551

  Moon, Yoomi ^a,b   Dahlberg, William K ^a   Yu, Yongjia ^a   Ohno, Tadao ^c   Todoroki, Takeshi ^b   Little, John B ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

biliary tract cancer; ionizing radiation; radiosensitivity; tumor suppressor gene

Indexed keywords

PROTEIN P53;

ARTICLE; BILE DUCT CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; TUMOR CELL LINE;

EID: 0030899826     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.3.545     Document Type: Article

References (55)

1. Smoron GL: Radiation therapy of carcinoma of the gallbladder and bile tract. Cancer 40: 1422-1424, 1977.
2. Kopelson G, Harisiadis L, Tretter P and Chang CH: The role of radiation therapy in cancer of the extra-hepatic biliary system: an analysis of thirteen patients and review of the literature of the effectiveness of surgery, chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2: 883-894, 1977.
3. Hanna SS and Rider WD: Carcinoma of the gallbladder or extra hepatic bile duct: The role of radiotherapy. Can Med Assoc J 118: 59-61, 1978.
4. Pilepich MV and Lambert PM: Radiotherapy of carcinomas of the extrahepatic biliary system. Radiology 127: 767-770, 1978.
5. Bosset JF, Mantion G, Gillet M, Pelissier E, Boulenger M, Maingon P, Corbion O and Schraub S: Primary carcinoma of the gallbladder: Adjuvant post operative external irradiation. Cancer 64: 1843-1847, 1989.
6. Houry S, Schlienger M, Huguier M, Lacaine F, Penne F and Laugier A: Gallbladdder carcinoma: Role of radiation therapy. Br J Surg 76: 448-450, 1989.
7. Verbeek PCM, Van Leeuwen DJ, Van Der Heyde MN and Gonzalez DG: Does additive radiotherapy after hilar resection improve survival of cholangiocarcinoma? analysis in sixty-four patients. Ann Chir 45: 350-354, 1991.
8. Herskovic A, Heaston D, Engler MJ, Fishburn RI, Jones RS and Noell KT: Irradiation of biliary carcinoma. Radiology 139: 219-222, 1981.
9. Chitwood WR, Meyers WC, Heaston DK, Herskovic AM, Mcleod ME and Jones RS: Diagnosis and treatment of primary extrahepatic bile duct tumors. Am J Surg 143: 99-106, 1982.
10. Conroy RM, Shanbazian AA, Edwards KC, Moran EM, Swingle KF, Lewis GL and Pribram HF: A new method for treating carcinomas biliary obstraction with intracatheter radium. Cancer 49: 1321-1327, 1982.
11. Karani J, Fretcher M, Brinkley D, Dawson JL, Williams R and Nunnerley H: Internal biliary drainage and local radiotherapy with iridium-192 wire in treatment of hilar cholangiocarcinoma. Clin Radiol 36: 603-606, 1985.
12. Fierds JN and Mani BE: Carcinoma of the extrahepatic biliary system-results of primary and adjubant radiotherapy. Int J Radiat Oncol Biol Phys 13: 331-338, 1987.
13. Mahe M, Romestaing P, Talon B, Ardiet J, Salerno N, Sentenac I and Gerard J: Radiation therapy in extrahepatic bile duct carcinoma. Radiother Oncol 21: 121-127, 1991.
14. Fritz P, Brambs H, Schraube P, Freund U, Berns C and Wannenmacher M: Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas. Int J Radiat Oncol Biol Phys 29: 855-861, 1994.
15. Todoroki T, Iwasaki Y, Okamura T, Nagoshi K, Asakura H, Nakano M, Inada T, Tsunemoto H, Umegaki Y, Nishimura A, Nakao M and Sato H: Intraoperative radiotherapy for advanced carcinoma of biliary system. Cancer 46: 2179-2184, 1980.
16. Deziel DJ, Kiel KD, Kramer TS, Doolas A and Roseman DL: Intraoperative radiation therapy in biliary tract cancer. Am Surg 54: 402-407, 1988.
17. Busse PM, Cady B, Bothe A, Jenkins R, McDermott WV, Steele G and Stone MD: Intraoperative radiation therapy for carcinoma of gallbladder. World J Surg 15: 352-356, 1991.
18. Todoroki T, Iwasaki Y, Orii K, Otsuka M, Ohara K, Kawamoto T and Nakamura K: Resection combined with Intraoperative Radiation Therapy (IORT) for stage IV (TNM) gallbladder carcinoma. World J Surg 15: 357-366, 1991.
19. Schoenthaler R, Phillips TL, Castro JR, Efird JT, Better A and Way LW: Carcinoma of extrahepatic bile ducts. The University of California at San Francisco experience. Ann Surg 219: 267-274, 1994.
20. Pitt HA, Nakeeb A, Abrams RA, Coleman J, Piantadosi S, Yeo CJ, Liliemoe KD and Cameron JL: Perihilar cholangiocarcinoma. Post operative radiotherapy does not improve survival. Ann Surg 221:788-798, 1995.
21. Miller SA, Dykes DD and Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988.
22. Sambrook J, Fritsch EF and Maniatis T: Molecular cloning: A Labolatory Manual. 2nd edition. Cold Spring Harbor Laboratory. Cold Spring Harbor, NY, pp 18.60-18.75, 1989.
23. Toguchida J, Yamaguchi T, Richie B, Beauchamp RL, Dayton SH, Herrera GE, Yamamuro Y, Kotoura Y, Sasaki MS, Little JB, Weichselbaum RR, Ishizaki K and Yandell DW: Mutation spectrum of the p53 gene in bone and soft tissue sarcoma. Cancer Res 52: 6194-6199, 1992.
24. Weichselbaum RR, Dahlberg WK, Beckett MA, Karrison T, Clark J and Ervin TJ: Radiation resistant and repair proficient human tumor cells may be associated with radiotherapy failure in head and neck cancer patients. Proc Natl Acad Sci USA 83: 2684-2688, 1986.
25. Rofstad EK, Wahl A and Brustad T: Radiation sensitivity in vitro of cells isolated from human tumor surgical specimens. Cancer Res 47: 106-110, 1987.
26. Brock WA, Baker FL, Wilke JL, Sivon SL and Peters LJ: Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int J Radiat Oncol Biol Phys 18: 1283-1286, 1990.
27. Allanius-Turner MJ, Barron GM, Day RS, Fulton DS and Urtasun RC: Radiosensitivity testing of human brain tumor specimens. Int J Radiat Oncol Biol Phys 23: 339-343, 1992.
28. Fertil B and Malaise EP: Inherent cellular radiosensitivity as a basic comcept for human tumor radiotherapy. Int J Radiat Oncol Biol Phys 7: 621-629, 1985.
29. Fertil B and Malaise EP: Intrinsic radiosensitivity of human cell lines is correlated with radiorcsponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 11: 1699-1707, 1985.
30. Fertil B, Dertinger H, Courdi A and Malaise EP: Mean inactivation dose: A useful concept for intercomparison of human cell survival curves. Radiat Res 99: 73-84, 1984.
31. Deacon J, Peckham MJ and Steel GG: The radiorcsponsiveness of human tumors and the initial slope of the cell survival curve. Radiother Oncol 2: 317-323, 1984.
32. West CML, Davidson SE and Hunter RD: Evaluation of surviving fraction at 2 Gy as a potential prognostic factor for the radiotherapy of carcinoma of the cervix. Int J Radiat Biol 56: 761-765, 1989.
33. Hunter RD: The radiotherapy of malignant disease. Pointon RCS (ed). Springer Verlag, Berlin, pp279-308, 1991.
34. West CML, Davidson SE, Hendry JH and Hunter RD: Prediction of cervical carcinoma responce to radiotherapy. Lancet 338: 818, 1991.
35. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253:49-53, 1991.
36. Caron de Fromentel C and Soussi T: p53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosom Cancer 4: 1-15, 1992.
37. Levine AJ, Momad J and Finlay CA: The p53 tumor suppressor gene. Nature 351: 453-456, 1991.
38. Furihata M, Sonobe H and Ohtsuki Y: The aberrant p53 protein (Review). Int J Oncol 6: 1209-1226, 1995.
39. Kamel D, Paakko P, Nuorva K, Vahakangas K and Soini Y: p53 and c-erb-2 protein expression in adenocarcinomas and epithelial dysplasias of the gallbladder. J Pathol 170: 67-72, 1993.
40. Wee A, The M and Raju GC: Clinical importance of p53 protein in gallbladder carcinoma and its precursor lesions. J Clin Pathol 47:453-456, 1994.
41. Oohashi Y, Watanabe H, Ajioka Y and Hatakeyama K: p53 immunostaining distinguishes malignant from benign lesions of the gallbladder. Pathol Int 45: 58-65, 1995.
42. Lee JM and Bernstein A: p53 mutation increasing resistance to ionizing radiation. Proc Natl Acad Sci USA 90: 5742-5746, 1993.
43. Tsang N-M, Nagasawa H, Li C-Y and Little JB: Abrogation of p53 function by transfection of HPV 16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. Oncogcne 10: 2403-2408, 1995.
44. Brachman DG, Beckett M, Graves D, Haraf D, Yokes E and Weichselbaum RR: p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 53: 3667-3669, 1993.
45. Slichenmyer WJ, Nelson WG, Slebos RJ and Kasten MB: Loss of p53-associated G1 check point does not decrease cell survival following DNA damage. Cancer Res 53:4164-4168, 1993.
46. Li C-Y. Nagasawa H, Dahlberg WK and Little JB: Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines. Oncogene 11: 1885-1892, 1995.
47. Huang H, Li C-Y and Little JB: Abrogation of p53 function by transfection of HPV 16 E6 gene does not enhance of resistance of human tumor cells to ionizing radiation. Int J Radiat Biol 70: 151-160, 1996.
48. Nagasawa H, Li C-Y, Maki CG, Imrich AC and Little JB: Relationship between radiation induced G1 phase arrest and p53 function in human tumor cells. Cancer Res 55: 1842-1846, 1995.
49. Fletcher GH: Textbook of Radiotherapy. 3rd edition. Lea & Febiger, Philadelphia, 1980.
50. Koperson G, Galdabini J, Warshaw AL and Gunderson LL: Patterns of failure after curative surgery for extra-hepatic billiary tract carcinoma: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 7: 413-417, 1981.
51. Buskurk SJ, Gunderson LL, Schild SE, Bender CE, Williams HJ, Mcilrath DC, Robinow JS, Tremainc WJ and Martin JK: Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma. Ann Surg 215: 125-131, 1991.
52. Tsuzuki T, Kuramochi S, Sugioka A, Ueda M, Iida S and Nakanishi I: Postresection autopsy findings in patient with cancer of the main hepatic duct junction. Cancer 67: 3010-3013, 1991.
53. Dahlberg WK, Little JB, Fletcher JA, Suit HD and Okunieff P: Radiosensitivity in vitro of human soft tissue sarcoma cell lines and skin fibroblast derived from the same patients. Int J Radiat Biol 63: 191-198, 1993.
54. Weichselbaum RR, Dahlberg WK and Little JB: Inherently radioresistant cells exist in some human tumors. Proc Natl Acad Sci USA 82: 4732-4735, 1985.
55. Little JB, Nove J, Strong LC and Nichols WW: Survival of human diploid skin fibroblast from normal individuals after X-irradiation. Int J Radiat Biol 54: 899-910, 1988.